Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05127590
Title RBN-2397 in Combination With Pembrolizumab in Patients With SCCL
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Ribon Therapeutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | GBR | ESP


No variant requirements are available.